Recombinant Pan troglodytes NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 (NDUFB4) is an accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). It is not believed to be directly involved in catalysis. Complex I facilitates electron transfer from NADH to the respiratory chain, with ubiquinone considered its immediate electron acceptor.
NDUFB4 is a non-catalytic subunit of the multisubunit NADH:ubiquinone oxidoreductase (complex I), the first enzyme complex in the mitochondrial electron transport chain. Pan troglodytes NDUFB4 shows high sequence homology with human NDUFB4, reflecting their close evolutionary relationship.
When studying structural differences, researchers should:
Employ comparative sequence analysis using tools such as BLAST or Clustal Omega
Utilize protein modeling software (PyMOL, SWISS-MODEL) to predict structural variations
Consider X-ray crystallography or cryo-EM for definitive structural determination
Based on evolutionary analyses, the Pan troglodytes NDUFB4 protein is expected to maintain key functional domains similar to those in humans, particularly in regions involved in protein-protein interactions within complex I .
Multiple expression systems have been successfully employed for NDUFB4 production:
| Expression System | Advantages | Limitations | Tag Options |
|---|---|---|---|
| E. coli | High yield, cost-effective | May lack post-translational modifications | His, GST |
| Mammalian Cells (HEK293) | Native-like folding and modifications | Lower yield, higher cost | His, Fc, Non-tagged |
| Cell-free systems | Rapid production, avoids toxicity issues | Relatively expensive | Multiple options |
Methodological approach:
For structural studies: E. coli expression with an N-terminal His-tag provides sufficient protein for crystallization attempts
For functional studies: HEK293 cells maintain native-like folding and post-translational modifications
For interaction studies: Consider dual-expression systems with potential binding partners
Research shows that incorporating membrane-mimicking environments during purification significantly improves stability of the recombinant protein .
To evaluate proper incorporation of recombinant NDUFB4 into complex I:
Blue-native PAGE (BN-PAGE) with subsequent immunoblotting using anti-NDUFB4 or anti-complex I antibodies
Complex I enzyme activity assays:
NADH:ubiquinone oxidoreductase activity measurements
NADH oxidase staining of tissue sections
Proteoliposome reconstitution followed by functional assays
Methodological considerations:
Digitonin solubilization preserves supercomplexes better than other detergents
For BN-PAGE, concentration gradients (3-12%) offer optimal resolution
Activity assays should include controls for both CI-specific and CII-specific respiration
Recent research has shown that monitoring assembly intermediates can provide insights into the role of NDUFB4 in complex I biogenesis .
For optimal storage and stability of recombinant NDUFB4:
Store at -20°C for short-term use; -80°C for long-term storage
Avoid repeated freeze-thaw cycles; prepare working aliquots
For transmembrane proteins like NDUFB4, include appropriate detergents or lipids in storage buffers
Stability optimization strategies:
Buffer composition: 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 10% glycerol, and mild detergent (0.05% DDM)
Addition of reducing agents (1-5 mM DTT or 0.5-2 mM TCEP) to prevent oxidation
Use of protease inhibitors in working solutions
Research indicates that His-tagged versions typically maintain activity for up to 6 months at -80°C, while shelf life at 4°C is limited to approximately one week .
NDUFB4 plays a critical role in mitochondrial respiratory supercomplex assembly, particularly in the formation of the I₁III₂IV₁ "respirasome." Research has identified specific residues within NDUFB4 that interact with UQCRC1 from complex III through hydrogen bonds .
Methodological approaches to study NDUFB4's role in supercomplex formation:
Site-directed mutagenesis:
Target key residues (Asn24, Arg30) involved in supercomplex formation
Assess effects on respirasome assembly using BN-PAGE
Measure functional consequences via respiratory flux analysis
Proximity labeling techniques:
BioID or APEX2 fusion proteins to identify interacting partners
Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces
Functional assessment:
Oxygen consumption rate (OCR) measurements using Seahorse technology
Complex I-specific vs. Complex II-specific OXPHOS respiration comparison
Research findings demonstrate that NDUFB4 point mutations (N24A and R30A) impair I₁III₂IV₁ respirasome assembly and reduce mitochondrial respiratory flux by 31% (resting), 24% (leak), and 40% (maximal) compared to wild-type controls .
Evolutionary analyses suggest NDUFB4 has experienced positive selection during primate evolution. Research has identified three potentially adaptive amino acid changes in NDUFB4: serine at position 12, glutamic acid at 16, and tyrosine at 96 .
Methodological approaches for detecting adaptive evolution:
Comparative genomic analysis:
Calculate non-synonymous (dN) and synonymous (dS) substitution rates using PAML
Perform Z-test for positive selection using MEGA
Reconstruct ancestral sequences at all tree nodes
Selection pressure mapping:
Categorize amino acid changes as poorly conserved, medium conserved, medium-highly conserved, or highly conserved
Identify periods of positive selection in evolutionary history
Map selection pressure to functional domains
Functional validation of evolutionary changes:
Site-directed mutagenesis of adaptively selected residues
Comparative functional assays between species variants
Research has shown that NDUFB4 exhibits evidence of positive selection at specific timepoints in primate evolution, particularly preceding the emergence of apes and following the emergence of orangutans .
NDUFB4 interacts with multiple proteins within complex I and potentially other respiratory complexes. Understanding these interaction networks requires multifaceted approaches:
Physical interaction mapping:
Crosslinking mass spectrometry (XL-MS) to identify neighboring residues
Co-immunoprecipitation followed by mass spectrometry
Yeast two-hybrid or mammalian two-hybrid screening
Structural biology approaches:
Cryo-EM of intact complex I with focus on NDUFB4 position
Molecular dynamics simulations of subunit interfaces
Hydrogen-deuterium exchange mass spectrometry
Functional interaction assessment:
Knockout/knockdown of NDUFB4 followed by proteomics analysis
Assembly intermediate characterization via BN-PAGE
Complementation studies with mutant variants
Published interaction data shows that NDUFB4 directly interacts with NDUFS4, NDUFS5, NDUFS3, NDUFA6, NDUFA9, NDUFA11, NDUFA12, TIMMDC1, and complex III subunit UQCRC1 .
NDUFB4 mutations that impair respirasome formation lead to widespread metabolic alterations:
Metabolomic approaches:
Targeted metabolomics for TCA cycle intermediates
Untargeted metabolomics to identify novel affected pathways
Stable isotope labeling to track metabolic flux
Bioenergetic assessment:
Real-time analysis of oxidative phosphorylation and glycolysis (Seahorse XF)
ATP/AMP ratio measurements using luciferase-based assays
Lactate/pyruvate ratio determination
Redox state evaluation:
Measurement of NADH/NAD+ ratios
ROS detection using fluorescent probes
Glutathione redox state assessment
Research indicates that NDUFB4 mutations (N24A, R30A) cause global decreases in citric acid cycle metabolites, particularly affecting NADH-generating substrates. Additionally, there is a metabolic shift from complex I-linked to complex II-linked respiration as a compensatory mechanism .
NDUFB4 dysfunction may contribute to mitochondrial diseases, particularly complex I deficiency. Researchers can investigate its role using:
Disease model development:
CRISPR/Cas9-mediated NDUFB4 knockout or knock-in of disease mutations
Patient-derived fibroblast or induced pluripotent stem cell (iPSC) studies
Conditional tissue-specific knockout animal models
Functional assessments:
High-resolution respirometry on isolated mitochondria
In vivo metabolic phenotyping (metabolic cages, glucose/insulin tolerance)
Histological and ultrastructural analysis of affected tissues
Therapeutic screening approaches:
Small molecule screens for complex I activity restoration
Gene therapy or mRNA delivery strategies
Metabolic bypass interventions
Research on related complex I subunits (particularly NDUFS4) shows promising results with genetic overexpression approaches improving cristae morphology, mitochondrial dynamics, and disease symptoms in diabetic kidney disease models .
Post-translational modifications (PTMs) may regulate NDUFB4 function and complex I assembly. To investigate these:
PTM identification strategies:
Phosphoproteomic analysis using TiO₂ enrichment
Ubiquitylome analysis following tryptic digestion and K-ε-GG enrichment
Acetylome analysis using anti-acetyl lysine antibodies
Functional validation approaches:
Site-directed mutagenesis of modified residues (phospho-mimetic or non-modifiable)
Enzymatic manipulation of PTMs (phosphatase/kinase treatment)
Temporal analysis during complex I assembly/disassembly
Regulation studies:
Response to oxidative stress, hypoxia, or other cellular stressors
Kinase/phosphatase inhibitor screens
Interaction changes dependent on modification state
While specific PTM data for NDUFB4 is limited in the current literature, research on other complex I subunits suggests that phosphorylation and acetylation may regulate assembly, stability, and activity of the respiratory complexes, offering potential research directions for NDUFB4 .